BC
Bain Capital Life Sciences Opportunities III, LP disclosed a 9.6% stake in CABA
Bain Capital Life Sciences Opportunities III, LP reported owning 9.6% of Cabaletta Bio, Inc. (CABA) (21,209,188 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.